Literature DB >> 9873716

Mixed-backbone oligonucleotides as second-generation antisense agents with reduced phosphorothioate-related side effects.

W Zhou1, S Agrawal.   

Abstract

Mixed-backbone oligonucleotides containing alternative phosphorothioate and phosphodiester linkages in the 2'-O-methylribonucleosides segment show increased affinity with complementary targets, increased stability towards nucleases in vitro and in vivo, and reduced phosphorothioate-related prolongation of partial thromboplastin time compared to phosphorothioate oligodeoxynucleotides, thereby providing antisense agents with reduced side effects.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9873716     DOI: 10.1016/s0960-894x(98)00591-5

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  9 in total

1.  Potent and nontoxic antisense oligonucleotides containing locked nucleic acids.

Authors:  C Wahlestedt; P Salmi; L Good; J Kela; T Johnsson; T Hökfelt; C Broberger; F Porreca; J Lai; K Ren; M Ossipov; A Koshkin; N Jakobsen; J Skouv; H Oerum; M H Jacobsen; J Wengel
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

2.  MicroRNA-feedback loop as a key modulator of liver tumorigenesis and inflammation.

Authors:  Angélique Gougelet; Sabine Colnot
Journal:  World J Gastroenterol       Date:  2013-01-28       Impact factor: 5.742

3.  Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death.

Authors:  B Herbert; A E Pitts; S I Baker; S E Hamilton; W E Wright; J W Shay; D R Corey
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

4.  Solution structure of an arabinonucleic acid (ANA)/RNA duplex in a chimeric hairpin: comparison with 2'-fluoro-ANA/RNA and DNA/RNA hybrids.

Authors:  A Y Denisov; A M Noronha; C J Wilds; J F Trempe; R T Pon; K Gehring; M J Damha
Journal:  Nucleic Acids Res       Date:  2001-11-01       Impact factor: 16.971

5.  Molecular and cellular barriers limiting the effectiveness of antisense oligonucleotides.

Authors:  Charles M Roth
Journal:  Biophys J       Date:  2005-07-29       Impact factor: 4.033

6.  Introduction and History of the Chemistry of Nucleic Acids Therapeutics.

Authors:  Michael J Gait; Sudhir Agrawal
Journal:  Methods Mol Biol       Date:  2022

Review 7.  Antisense Oligonucleotide Therapy: From Design to the Huntington Disease Clinic.

Authors:  Morgan E Rook; Amber L Southwell
Journal:  BioDrugs       Date:  2022-03-07       Impact factor: 7.744

8.  Advances in antisense oligonucleotide development for target identification, validation, and as novel therapeutics.

Authors:  Moizza Mansoor; Alirio J Melendez
Journal:  Gene Regul Syst Bio       Date:  2008-09-22

Review 9.  The Evolution of Antisense Oligonucleotide Chemistry-A Personal Journey.

Authors:  Sudhir Agrawal
Journal:  Biomedicines       Date:  2021-05-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.